Treatment with high doses of radiotherapy may significantly boost survival for patients with mesothelioma, according to new findings. New results from a randomized clinical trial show that patients ...

Tumor treating fields are emerging as a promising option for treating a range of cancer types. Here’s a look at the evidence ...

NORTH PHILADELPHIA (WPVI) -- Mesothelioma is one of the hardest cancers to treat, but from surgical techniques to drug combinations, progress is slowly being made, giving patients more time and ...

May 16 -- THURSDAY, May 15 (HealthDay News) -- Adding chemotherapy to other treatments being giving to patients with mesothelioma, a lung cancer usually linked to asbestos exposure, does not appear to ...

RAHWAY, N.J. & KINGSTON, Ontario--(BUSINESS WIRE)-- Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and the Canadian Cancer Trials Group (CCTG) today announced that the Phase ...

An innovative treatment significantly increases the survival of people with malignant mesothelioma, a rare but rapidly fatal type of cancer with few effective treatment options, according to results ...

Postoperative Radiotherapy for Stage II or III Non–Small-Cell Lung Cancer Using the Surveillance, Epidemiology, and End Results Database Phase II cancer clinical trials play a key role in the ...

Based on results from the CheckMate743 trial, the dual regimen of ipilimumab and nivolumab is the standard of care for the treatment of unresectable pleural mesothelioma. But research published today ...

Keytruda and Lenvima combination shows promising results for pleural mesothelioma after chemotherapy failure, with a 58% objective response rate. The PEMMELA trial reported a median progression-free ...

Mayo Clinic researchers have developed an innovative testing strategy for mesothelioma that could potentially increase the detection rate of cancer DNA in the blood. This approach focuses on shuffled ...